While the gradual erosion of cognitive faculties is widely anticipated as an inevitable consequence of advancing years, a distinct cohort of individuals, aptly designated "SuperAgers," consistently defies this expectation. These remarkable octogenarians and nonagenarians exhibit memory capabilities that not only rival but often surpass those observed in individuals a quarter-century younger, typically in their 50s and 60s. For nearly two decades, the scientific community has diligently sought to pinpoint the confluence of biological, neurological, and psychosocial attributes that underpin this phenomenon of preserved youthful cognition. A persistent and pivotal inquiry has been whether SuperAgers represent a population predisposed by an inherently low genetic susceptibility to Alzheimer’s disease.
Dr. Emily Rogalski, a pioneering researcher and the architect of the SuperAging definition in 2008, who has dedicated her career to studying this unique demographic through her leadership at the Healthy Aging & Alzheimer’s Research Care (HAARC) Center at the University of Chicago, articulated the potential simplicity of this genetic hypothesis. "If this were the sole determinant," she posited, "the identification of SuperAgers could be as straightforward as a genetic screening, obviating the need for the extensive and multifaceted cognitive assessments we presently employ."
To rigorously test this prevailing genetic explanation for SuperAging, an extensive research endeavor was undertaken, analyzing the largest prospectively enrolled SuperAging cohorts utilizing the most advanced metrics for assessing inherited Alzheimer’s disease risk. The findings, meticulously documented and disseminated in the esteemed journal Alzheimer’s Research & Therapy, strongly indicate that the preservation of extraordinary memory function in later life cannot be attributed solely to a low genetic predisposition. This revelation underscores the critical imperative to delve deeper into the protective biological mechanisms that empower certain individuals to sustain exceptionally robust cognitive abilities well into their advanced years.
The collaborative effort, involving researchers from the HAARC Center and the Translational Genomics Research Institute (TGen), an integral part of City of Hope, encompassed a diverse participant pool drawn from five distinct research centers across the United States and Canada. This significant study cohort comprised 142 individuals identified as SuperAgers and a control group of 89 older adults exhibiting average cognitive performance for their age.
Leveraging DNA samples meticulously extracted from blood specimens, the research team meticulously analyzed the APOE gene, widely recognized as the most significant genetic determinant of Alzheimer’s disease risk. Furthermore, they computed three distinct polygenic risk scores. These sophisticated scores are designed to aggregate the influence of thousands of genetic variants known to be associated with an inherited predisposition to Alzheimer’s disease, thereby offering a more comprehensive picture of genetic vulnerability.
The analytical outcomes decisively challenged the prevailing notion that SuperAgers are inherently shielded from cognitive decline due to a reduced burden of Alzheimer’s-related genetic risk variants. The investigative team was unable to differentiate SuperAgers from their cognitively average counterparts based on either their APOE genotype or their scores on the Alzheimer’s polygenic risk assessments. In essence, the evidence suggests that the remarkable feat of maintaining exceptional memory in one’s 80s does not appear to stem from an exceptionally low inherited risk for Alzheimer’s disease.
Dr. Ana Capuano, co-first author of the study and director of the biostatistics core at the HAARC Center, emphasized the broader implications of these findings. "These results strongly reinforce the understanding that the preservation of cognitive health transcends merely mitigating the risk of Alzheimer’s disease," she stated. "Unraveling the intricate interplay of biological, behavioral, and social factors that foster exceptional cognitive aging holds the potential to significantly augment traditional disease-centric approaches and pave the way for the development of more individualized strategies aimed at nurturing brain health throughout the entire human lifespan."
Beyond the common genetic risk factors, the researchers also scrutinized rare genetic variants previously implicated in conferring protection or resilience against Alzheimer’s disease. However, these protective variants did not demonstrate a greater prevalence among the SuperAger cohort compared to the control group, further diminishing the likelihood of a simple genetic explanation.
Dr. Matt Huentelman, a professor and director within TGen’s Early Detection and Prevention Division and co-senior author alongside Dr. Rogalski, underscored the study’s significance in delineating the boundaries of current Alzheimer’s disease genetics. "This research establishes a critical demarcation point concerning Alzheimer’s disease genetics," he observed. "The common genetic risk factors captured by APOE and contemporary polygenic risk scores are insufficient to account for the SuperAging phenotype. Future investigations must transcend disease-risk models and explore the expansive array of biological, environmental, and experiential pathways that contribute to exceptional cognitive aging."
The path forward involves the adoption of a comprehensive, multidisciplinary research strategy. Future studies are slated to integrate an extensive battery of assessments, including detailed cognitive evaluations, advanced brain imaging techniques, analysis of blood biomarkers, genetic profiling, examination of neuropathological changes, immune system profiling, monitoring of sleep patterns and physical activity, and the measurement of social and environmental influences, all contributing to a holistic understanding of an individual’s health.
Dr. Ignazio S. Piras, an associate professor in TGen’s Early Detection and Prevention Division and another co-first author, highlighted the evolution of aging research. "For many years, the primary focus of aging research has been on identifying factors that elevate the risk of disease," he explained. "While those investigations are undeniably crucial, the mere absence of risk factors does not inherently signify the presence of protective elements that bolster exceptional brain health. This study serves as a vital demonstration of that critical distinction."
The cumulative findings offer a profoundly encouraging message: the decline of memory is not an immutable destiny. A subset of individuals demonstrably possesses the capacity – and indeed, the reality – to maintain remarkably youthful memory function well into their ninth and tenth decades of life. While the precise mechanisms by which SuperAgers achieve such enduring cognitive prowess remain an active area of scientific inquiry, the ongoing exploration is significantly aided by the very individuals who embody this extraordinary phenomenon. These dedicated long-term research volunteers have generously contributed years of their lives, enabling scientists to not only define the characteristics of successful cognitive aging but also to illuminate novel pathways that may foster resilience against cognitive decline. This groundbreaking work was generously supported by the National Institute on Aging (U19AG073153), the McKnight Brain Research Foundation through the SuperAging Research Initiative, and the Simons Foundation, in addition to the invaluable contributions of numerous participants, their families, and the dedicated researchers across the five collaborating study sites.
About the Author
